The effect of parathyroid hormone (1–84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis
Crossref DOI link: https://doi.org/10.1007/s40618-017-0636-8
Published Online: 2017-02-25
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pepe, J.
Cipriani, C.
Cantatore, F. P.
Fabbri, A.
Pola, E.
Vinicola, V.
Raimo, O.
Biamonte, F.
Pascone, R.
Ferrara, C.
Minisola, S.
License valid from 2017-02-25